PINL:GRPOF - Post by User
Comment by
Kingofstockston Apr 06, 2020 11:20am
153 Views
Post# 30882908
RE:Type b
RE:Type b On May 29, the FDA will be providing guidance on our planned phase 2 clinical trial, expedited review paths, and 505(b)(2) premarketing requirements. Tetra also plans to provide the FDA with data from our ongoing metabolite study". Isn't that the answer?